CRISPR/Cas bioimaging: From whole body biodistribution to single-cell dynamics

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Optical Imaging

Background:

• CRISPR/Cas systems are powerful gene-editing tools.
• Optical imaging techniques like NIR and fluorescence benefit from nanoformulated contrast agents.
• Efficient delivery and targeted tracking of CRISPR/Cas systems are crucial for therapeutics and diagnostics.

Purpose of the Study:

• To review the integration of CRISPR/Cas systems with nanoparticle (NP) technologies for optical bioimaging.
• To highlight advancements in visualizing gene-editing processes in vitro and in vivo.
• To discuss the potential of CRISPR/Cas-based bioimaging in precision medicine and theranostics.

Main Methods:

• Integration of CRISPR/Cas systems with advanced optical imaging modalities (NIR, fluorescence).
• Development of CRISPR/Cas-loaded nanoparticles (NPs) for enhanced imaging and delivery.
• Utilizing biomimetic NPs to improve biocompatibility, targeting, and overcome biological barriers.

Main Results:

• CRISPR/Cas-loaded NPs enable enhanced, real-time, and quantitative monitoring of gene editing processes.
• Multiplexed and multicolor imaging capabilities are achieved for complex biological settings.
• Biomimetic NPs facilitate improved in vivo delivery and bioimaging of CRISPR/Cas systems.

Conclusions:

• CRISPR/Cas-based optical bioimaging, powered by NP advancements, offers precise monitoring of gene editing.
• This technology holds significant promise for in vivo diagnostics and targeted therapeutics.
• Continued improvements in NP design and delivery mechanisms will drive advancements in precision medicine and theranostics.